These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6984947)

  • 1. [Isoniazid acetylation in São Paulo descendants of Japanese].
    Garlipp CR; Ramalho AS; Beiguelman B
    AMB Rev Assoc Med Bras; 1982; 28(7-8):179-81. PubMed ID: 6984947
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
    Kohno H; Mori M; Katayama T
    Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isoniazid acetylation among Brazilian Caucasoids and Negroids with pulmonary tuberculosis].
    Beiguelman B; Ramalho AS; Arena JF; Garlipp CR
    Rev Paul Med; 1977; 89(1-2):12-5. PubMed ID: 918481
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variability of isoniazid pharmacokinetics].
    Sokolova GB; Ivleva AIa; Ziia AV; Vilenskaia RN
    Farmakol Toksikol; 1982; 45(3):101-4. PubMed ID: 7095118
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isoniazid acetylation in Gilbert's syndrome].
    Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF
    Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase activity in the urine in Japanese subjects: comparison in healthy persons and bladder cancer patients.
    Ishizu S; Hashida C; Hanaoka T; Maeda K; Ohishi Y
    Jpn J Cancer Res; 1995 Dec; 86(12):1179-81. PubMed ID: 8636007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid acetylator phenotyping of Amharas in Ethiopia.
    Russell SL; Russell DW
    Afr J Med Sci; 1973 Jan; 4(1):1-5. PubMed ID: 4695980
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylation phenotyping of isoniazid using a simple and accurate high-performance liquid chromatography.
    el-Sayed YM; Islam SI
    J Clin Pharm Ther; 1989 Jun; 14(3):197-205. PubMed ID: 2760118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis].
    Ligueros M; Cruz Coke R; Neira S; Saavedra H; Kramer V; Prieto JC; Gelman M; Saavedra A; Nuñez A; Pescio S
    Rev Med Chil; 1989 Dec; 117(12):1339-43. PubMed ID: 2519370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular genotyping of N-acetylation polymorphism to predict phenotype.
    Mashimo M; Suzuki T; Abe M; Deguchi T
    Hum Genet; 1992; 90(1-2):139-43. PubMed ID: 1427770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.
    Eidus L; Hodgkin MM; Hsu AH; Schaefer O
    Am Rev Respir Dis; 1974 Jul; 110(1):34-42. PubMed ID: 4834616
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
    Gontsa FT; Savina LA; Tsurkan VP; Kovalenko IP
    Probl Tuberk; 1988; (2):35-8. PubMed ID: 3375215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.